The Dural Medical Glue segmentation by application distinguishes four primary usage domains that collectively drive market revenue. Neurosurgery accounts for the largest share, roughly 45% of total sales, as the adhesive is employed for dural closure, cerebrospinal fluid leak prevention, and cranial defect sealing, where high biocompatibility and rapid polymerization are critical. Orthopedics follows with an estimated 30% contribution, reflecting the glue’s role in bone fragment fixation, tendon-to-bone attachment, and minimally invasive joint repair, where mechanical strength and load‑bearing capacity dominate purchasing decisions. Cardiovascular procedures represent about 15% of the market, leveraging the adhesive for vessel sealing, aneurysm repair, and graft fixation, with emphasis on hemostasis and endothelial compatibility. The remaining Other applications—encompassing otolaryngology, ophthalmology, and veterinary surgery—contribute roughly 10%, illustrating niche adoption where specific tissue‑type requirements dictate product selection. These percentages are directly proportional to procedure volume, reimbursement rates, and clinical outcome data, thereby shaping the overall market size.
